Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AMAG Pharmaceuticals Inc (NASDAQ:AMAG)

63.49
BATS BZX Real-Time Price
As of 11:16am ET
 -1.50 / -2.31%
Today’s Change
22.47
Today|||52-Week Range
77.73
+48.97%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.2B

Company Description

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. It focused on the development and commercialization of Feraheme injection for intravenous or IV, use to treat iron deficiency anemia or IDA. The company engages in manufacture, development and commercialization of products derived from its proprietary technology for use in treating human diseases. AMAG Pharmaceuticals was founded in November 1981 and is headquartered in Waltham, MA.

Contact Information

AMAG Pharmaceuticals, Inc.
1100 Winter Street
Waltham Massachusetts 02451
P:(617) 498-3300
Investor Relations:

Employees

Shareholders

Mutual fund holders68.56%
Other institutional58.89%
Individual stakeholders15.73%

Top Executives

William K. HeidenChief Executive Officer & Executive Director
Frank E. ThomasPresident, COO, CFO & CAO
Scott T. McMillanSenior VP-Quality & Technical Operations
Robert KaperSenior Vice President-Medical & Scientific Affairs
Julie KropChief Medical Officer & SVP-Clinical Development